Across TCGA pan-cancer cohorts, OR11A1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR11A1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR11A1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR11A1 is over-expressed in tumor.

KIRC, UCEC, and PRAD are the cancer types where OR11A1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR11A1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.007	.022	5	view →
UCEC	All	IV	+0.230	.028	2	view →
PRAD	All	All	+0.006	.038	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR11A1 RNA expression & survival · all OR11A1 data types